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SUMMARY
Deamidation of N-terminal Gln by the Ntaq1 NtQ-amidase is a part of the Arg/N-end rule
pathway, a ubiquitin-dependent proteolytic system. Here we identify Gln-Usp1Ct, the C-terminal
fragment of the autocleaved Usp1 deubiquitylase, as the first physiological Arg/N-end rule
substrate that is targeted for degradation through deamidation of N-terminal Gln. Usp1 regulates
genomic stability, in part through the deubiquitylation of monoubiquitylated PCNA, a DNA
polymerase processivity factor. The autocleaved Usp1 remains a deubiquitylase because its
fragments remain associated with Uaf1, an enhancer of Usp1 activity, until the Gln-Usp1Ct
fragment is selectively destroyed by the Arg/N-end rule pathway. We also show that metabolic
stabilization of Gln-Usp1Ct results in a decreased monoubiquitylation of PCNA and in a
hypersensitivity of cells to ultraviolet irradiation. Thus, in addition to its other functions in DNA
repair and chromosome segregation, the Arg/N-end rule pathway regulates genomic stability
through the degradation-mediated control of the autocleaved Usp1 deubiquitylase.
INTRODUCTION
The ubiquitin (Ub) system plays major roles in responses of cells to DNA damage (Ciccia
and Elledge, 2010; Huang and D’Andrea, 2006; Jentsch et al., 1987; Kim and D’Andrea,
2012; Ulrich, 2011). Some of these responses involve cycles of monoubiquitylation-
deubiquitylation of specific proteins. The functions of the Usp1 deubiquitylase (DUB) in the
control of genomic stability include the Usp1-mediated deubiquitylation of the
monoubiquitylated FancD2, FancI, and PCNA (Cohn et al., 2007; Cotto-Rios et al., 2011a;
Huang et al., 2006; Jones et al., 2012; Kim and D’Andrea, 2012; Moldovan et al., 2007;
Ulrich, 2011). The FancD2-FancI heterodimer is a component of the Fanconi anemia (FA)
pathway, whose major function is repair of DNA interstrand crosslinks (Kim and D’Andrea,
2012; Ulrich, 2011). PCNA is the DNA polymerase processivity factor that forms a sliding
homotrimeric ring around double-stranded DNA and specifically associates with different
types of DNA polymerases either in S phase replication forks or during episodes of localized
DNA synthesis that mediate DNA repair (Kim et al., 2009; Lange et al., 2011; Moldovan et
al., 2007; Murai et al., 2011; Ulrich, 2011). Upon DNA damage and/or perturbations of
DNA replication, PCNA is monoubiquitylated at a specific lysine by the Rad6-Rad18 E3-E2
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Ub ligase (Alpi and Patel, 2009; Fox et al., 2011; Hendel et al., 2011; Huang et al., 2006;
Kim and D’Andrea, 2012). Monoubiquitylated PCNA binds to damage-tolerant, error-prone
DNA polymerases of the Y family (Jones et al., 2012; Lange et al., 2011; Ulrich, 2011).
These polymerases contain Ub-binding domains that recognize monoubiquitylated PCNA.
Usp1 forms a heterodimeric complex with Uaf1 (Usp1-associated factor 1) (Wdr48), a
protein containing WD40-type repeats (Cohn et al., 2007, 2009; Villamil et al., 2012). The
binding of Uaf1 to Usp1 DUB strongly increases its deubiquitylating activity (Cohn et al.,
2007; Villamil et al., 2012). Usp1 is a conditionally short-lived protein. We have shown that
the APC/CCdh1 E3 Ub ligase targets Usp1 for the proteasome-mediated degradation in the
G1 phase of the cell cycle. Low levels of Usp1 in G1 allow an efficacious
monoubiquitylation of PCNA in response to UV-mediated DNA damage before DNA
replication (Cotto-Rios et al., 2011a, 2011b). During mitosis, phosphorylation of Usp1 by
cyclin-dependent kinases partially protects it against degradation via the APC/CCdh1 Ub
ligase (Cotto-Rios et al., 2011a).
Remarkably, Usp1 can also cleave itself, in a reaction accelerated by UV irradiation of
mammalian cells (Huang et al., 2006). Usp1 autocleaves immediately after the internal Gly-
Gly sequence (Figure 1A), which is identical to the C-terminal sequence of Ub. The C-
terminal fragment of Usp1, denoted as Gln-Usp1Ct, bears N-terminal Gln and contains a part
of the sequence (“His box”) that encompasses the active site of Usp1 (Figure 1A). The DUB
activity of autocleaved Usp1 can apparently be retained if the N-terminal fragment (denoted
as Usp1Nt) and Gln-Usp1Ct are held together within the cleaved Usp1-Uaf1 complex (Cohn
et al., 2007). Because Gln is a destabilizing residue in the N-end rule, the evolutionary
conservation of N-terminal Gln in Gln-Usp1Ct suggested that this fragment might be
targeted for degradation by the Arg/N-end rule pathway (Figures 1A and 1B and Figure S1
available online).
The N-end rule relates the in vivo half-life of a protein to the identity of its N-terminal
residue. Regulated degradation of proteins by the Ub/proteasome-dependent Arg/N-end rule
pathway mediates a strikingly broad range of biological functions (Dougan et al., 2011;
Graciet and Wellmer, 2010; Mogk et al., 2007; Piatkov et al., 2012; Tasaki et al., 2012;
Varshavsky, 2011) (Figure S1). The N-end rule pathway polyubiquitylates proteins that
contain specific degradation signals (degrons), either internal or N-terminal ones (N-
degrons) (Varshavsky, 2011). The main determinant of an N-degron is a destabilizing N-
terminal residue of a protein. Recognition components of the N-end rule pathway, called N-
recognins, are specific E3 Ub ligases that can target N-degrons. The N-end rule pathway
consists of two branches, the Ac/N-end rule and the Arg/N-end rule pathways. The Ac/N-
end rule pathway recognizes proteins with N-terminally acetylated residues (Hwang et al.,
2010b). The Arg/N-end rule pathway targets specific unacetylated N-terminal residues
(Hwang et al., 2010a; Varshavsky, 2011) (Figure S1). In eukaryotes, the primary
destabilizing N-terminal residues Arg, Lys, His, Leu, Phe, Tyr, Trp, and Ile are directly
recognized by E3 N-recognins. In contrast, N-terminal Asp, Glu, Asn, Gln, and Cys function
as destabilizing residues through their preliminary enzymatic modifications, which include
N-terminal deamidation (Nt-deamidation) of Asn and Gln, as well as Nt-arginylation of Asp,
Glu, and (oxidized) Cys (Figure S1) (Brower and Varshavsky, 2009; Tasaki et al., 2012;
Varshavsky, 2011; Wang et al., 2009).
Here we identify the Gln-Usp1Ct fragment of Usp1 as the first physiological substrate of the
Arg/N-end rule pathway that is targeted for degradation through deamidation of N-terminal
Gln, a reaction mediated by the Ntaq1-encoded NtQ-amidase (Wang et al., 2009) (Figure
S1). We also show that a metabolic stabilization of Gln-Usp1Ct, a change that prolongs DUB
Piatkov et al. Page 2
Mol Cell. Author manuscript; available in PMC 2014 January 13.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
activity of the autocleaved Usp1 in the Usp1-Uaf1 complex, makes cells hypersensitive to
UV irradiation.
RESULTS AND DISCUSSION
The C-Terminal Fragment of the Autocleaved Usp1 Deubiquitylase Is Deamidated and
Degraded by the Arg/N-End Rule Pathway
To determine whether the Gln-Usp1Ct fragment could be degraded by the Arg/N-end rule
pathway, we used the Ub reference technique (URT), derived from the Ub fusion technique
(Varshavsky, 2005, 2011). Cotranslational cleavage of a URT-based Ub fusion by DUBs
produces, at initially equimolar ratio, a test protein with a desired N-terminal residue and a
“reference” fDHFR-UbR48, a flag-tagged derivative of the mouse dihydrofolate reductase
(Figure 1C). In URT-based pulse-chase assays, the labeled test protein is quantified by
measuring its levels relative to the levels of a stable reference at the same time point during
a chase. In addition to being more accurate than pulse chases without a “built-in” stable
reference, URT makes it possible to measure the degradation of the test protein before the
chase, i.e., during the pulse (Hwang et al., 2010b; Piatkov et al., 2012; Varshavsky, 2005).
URT-based 35S pulse chases with  (X = Gln, Glu, Val) were
performed in a transcription-enabled rabbit reticulocyte extract, which contains the Arg/N-
end rule pathway and has been extensively used to analyze this pathway (Varshavsky,
2011).  fusions (X = Gln, Glu, Val) were labeled with 35S-
Met/Cys for 10 min at 30°C, followed by a chase, immunoprecipitation with anti-flag
antibody, SDS-PAGE, autoradiography, and quantification (Figures 1D and 1E). The logic
of these assays (Piatkov et al., 2012) involves a comparison between the degradation rates of
a protein bearing a destabilizing N-terminal residue and an otherwise identical protein with
an N-terminal residue such as Val, which is not recognized by the Arg/N-end rule pathway
(Figure S1).  and  were equally short-lived in reticulocyte extract
(t1/2 of ~20 min) (Figures 1D and 1E). Moreover, ~40% of pulse-labeled  and
 proteins were degraded during the pulse, before the chase, in comparison to
, which was stable (Figures 1D and 1E).
Cells Lacking Ntaq1 or Ate1 Contain Metabolically Stabilized Gln-Usp1Ct, the C-Terminal
Fragment of Autocleaved Usp1
To ascertain whether the Arg/N-end rule pathway mediated the degradation of the auto-
generated  fragment, we constructed Ntaq1−/− mouse strains and established
Ntaq1−/− embryonic fibroblast (EF) cell lines lacking the Gln-specific Ntaq1 NtQ-amidase
(see the Supplemental Experimental Procedures). Using a coupled enzymatic assay for Nt-
deamidation that utilized Nt-deamidation-dependent Nt-arginylation (Wang et al., 2009), we
found that extracts from Ntaq1−/− EFs were unable to deamidate N-terminal Gln of a protein
reporter, in contrast to extracts from wild-type EFs (Figure S2B). We concluded that Ntaq1
is the sole NtQ-amidase in mouse cells, and that Ntaq1−/− mice (and EF cells) lacked the
Gln-specific NtQ- amidase activity (see the Supplemental Experimental Procedures for
additional details). Ntaq1−/− mice were anatomically normal and fertile but behaviorally
abnormal, as will be described elsewhere (K.I.P. and AV., unpublished data). Degradation of
the autogenerated Gln-Usp1Ct fragment was examined using a cycloheximide (CHX) chase
assay (Hwang et al., 2010b) with wild-type EFs, Ntaq1−/− EFs (produced in the present
work), and previously produced Ate1−/− EFs (Kwon et al., 2002). Ate1−/− EF cell lines lack
the Ate1 R-transferase and therefore lack the arginylation branch of the Arg/N-end rule
pathway, downstream of its deamidation branch (Piatkov et al., 2012) (Figure S1).
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Full-length mouse Usp1 was a short-lived protein in all three EF cell lines (Figure 2A), in
agreement with the degradation of Usp1 through an internal degron (upstream of the
autocleavage site) that is targeted by the APC/CCdh1 Ub ligase (Cotto-Rios et al., 2011b),
and also, as shown below, through the ongoing autocleavage of Usp1 that generates a Gln-
specific N-degron. Although the Gln-Usp1Ct fragment (detected by the previously
characterized antibody [Huang et al., 2006] against C-terminal region of mouse or human
USP1 and termed anti-USP1Cterm) was present in all examined EF cellss, this fragment was
short lived in wild-type cells but long lived in both Ntaq1−/− and Ate1−/− EF cells (Figure
2A, middle panel), in agreement with the necessity of both Nt-deamidation (by Ntaq1) and
Nt-arginylation (by Ate1) for the targeting of N-terminal Gln (Figure 1B).
In other assays with wild-type, Ntaq1−/−, and Ate1−/− EF cells, they were transfected with
plasmids that expressed the C-terminally myc-tagged, full-length mouse Usp1 (Usp1-myc),
which yielded the  fragment upon autocleavage, or, alternatively, the
otherwise identical  mutant, which could not be autocleaved, owing to the Gly-
to-Ala mutation of the P1 residue in the autocleavage site (Huang et al., 2006) (Figure 1A).
In agreement with Gln-Usp1Ct being a short-lived Arg/N-end substrate (Figures 1D, 1E, and
2A), the C-terminally myc-tagged  fragment was short lived in wild-type EF
cells but long lived in both Ntaq1−/− EFs (Figure 2B) and Ate1−/− EF cells (Figure 2C, lanes
4–6, and Figure 2D, lanes 4–6). As expected (Huang et al., 2006), the  mutant did
not yield the  fragment (Figure 2C, lanes 7–9; compare with Figure 2D, lanes
7–9).
In further CHX chases, human U2OS cells were transfected with plasmids that expressed
either C-terminally myc-tagged mouse Usp1 (Usp1-myc) and its mutants Usp1G669A and
Usp1Q670A (Figure 2E) or N-terminally myc-tagged human USP1 (myc-USP1) and its
mutant USP1Q672A (Figure S2C). In agreement with the data about mouse Gln-Usp1Ct in
mouse cells (Figures 1D, 1E, and 2A–2D), wild-type mouse Usp1-myc gave rise to the
short-lived  fragment in human cells (Figure 2E, lanes 4–6). In contrast, the
otherwise identical full-length  mutant yielded much higher initial (and
subsequent) levels of the long-lived  fragment, whose (mutant) N-terminal
Ala is not recognized by the Arg/N-end rule pathway (Figure 2E, lanes 10–12; compare with
lanes 4–6). As expected, , which is resistant to autocleavage (Huang et al., 2006),
did not produce the  fragment in human cells (Figure 2E, lanes 7–9; compare
with lanes 4–6 and lanes 10–12).
The results of CHX-chases with the N-terminally myc-tagged human USP1 and its myc-
USP1Q672A mutant were in agreement with other findings about Gln-Usp1Ct and the
dependence of its degradation on N-terminal Gln (Figure S2C). In conjunction with anti-
USP1Cterm antibody, the N-terminal myc tag in myc-USP1 made it possible to detect the
formation of both the N-terminal USP1 fragment (myc-USP1Nt) and its C-terminal
(untagged) counterpart (X-Usp1Ct; either Gln-Usp1Ct or Ala-Usp1Ct). The metabolic
stability of the N-terminal myc-USP1Nt fragment (assessed by its levels after 3 hr CHX
chase) was significantly higher in the case of myc-USP1Q672A (it yielded long-lived Ala-
Usp1Ct) than in the case of wild-type myc-USP1 (it yielded short-lived Gln-Usp1Ct) (Figure
S2C). Because the bulk of USP1 in vivo is in the complex with UAF1 (see the Introduction),
a parsimonious interpretation of this result is that a metabolic stabilization of the C-terminal
USP1 fragment (in this experiment, through a change of its N-terminal residue from Gln to
Ala) stabilizes the N-terminal fragment as well. This would happen because both fragments
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of the autocleaved USP1 are bound to UAF1, thereby retaining the DUB activity of USP1
within this complex. In this interpretation, the selective destruction of Gln-Usp1Ct by the
Arg/N-end rule pathway also destabilizes the N-terminal USP1 fragment, possibly by
facilitating its dissociation from UAF1.
Metabolic Stabilization of Gln-Usp1Ct Results in a Decreased Monoubiquitylation of PCNA
and Hypersensitivity of Cells to UV Damage
In our working model, the targeting of the Gln-Usp1Ct fragment for degradation via its Arg/
N-degron is mechanistically coupled to fragment’s dissociation from Uaf1. If so, the Arg/N-
end rule pathway acts, in this setting, as a regulator that determines the duration of DUB
activity of the autocleaved Usp1 in the Usp1-Uaf1 complex. By selectively destroying Gln-
Usp1Ct, the Arg/N-end rule pathway would abrogate the DUB activity of the autocleaved
Usp1 and at the same time (according to this model) metabolically destabilize the N-
terminal Usp1 fragment. This “resetting” function of the Arg/N-end rule pathway recurs in
previously analyzed circuits, for example, during chromosome segregation in
Saccharomyces cerevisiae. Scc1, a subunit of yeast cohesin that holds together sister
chromatids, is cleaved by separase during mitosis, yielding the C-terminal fragment that
bears N-terminal Arg, a destabilizing residue (Figure S1), and remains associated with the
rest of cohesin (Rao et al., 2001). The selective destruction of the C-terminal fragment of
Scc1 by the Arg/N-end rule pathway has been shown to be required for the high fidelity of
chromosome segregation (Rao et al., 2001).
The Usp1-mediated deubiquitylation of monoubiquitylated PCNA makes Usp1 a negative
regulator of the UV-induced translesion DNA synthesis, mediated by damage-bypassing
DNA polymerases bound to monoubiquitylated PCNA (Lange et al., 2011; Moldovan et al.,
2007; Ulrich, 2011). We have previously shown that the autocleavage and inactivation of
Usp1 were augmented by UV irradiation of cells, thus accounting for an increase in both
steady-state levels of monoubiquitylated PCNA and damage-bypassing DNA synthesis upon
UV irradiation (Huang et al., 2006). For the reasons above, the demonstrated degradation of
Gln-Usp1Ct by the Arg/N-end rule pathway (Figures 1B–1D and 2) at least contributes to
(and possibly entirely mediates) the abrogation of DUB activity of the autocleaved Usp1. If
so, does the Arg/N-end rule pathway also play a role in the UV-induced DNA damage
response?
To address this question, we compared wild-type EF cells with mutant EFs that lacked
subsets of the Arg/N-end rule pathway. The levels of monoubiquitylated PCNA were greatly
reduced in Ate1−/− EF cells after UV irradiation, in comparison to wild-type EFs (Figure 3A,
middle panel, lane 2; compare with lane 4), consistent with higher levels of the active Usp1
DUB in these cells. These data indicated that the metabolic stabilization of Gln-Usp1Ct in
the absence of Nt-arginylation) was required for the DUB activity of autocleaved Usp1,
since both Ate1−/− and wild-type EFs had comparable levels of full-length Usp1 (Figure 3A,
lanes 2 and 4). In agreement with these results, both Ntaq1−/− EF cells and Ate1−/− EF cells
were significantly more sensitive to UV than were wild-type EF cells (Figure 3B).
In another approach, we replaced the destabilizing Gln672 P1’ residue (it becomes N-
terminal upon the autocleavage of USP1) with Met, a residue that is not recognized by the
Arg/N-end rule pathway (Figure S1). In addition, the open reading frame encoding the
USP1Q672M mutant was made resistant, through synonymous codon replacements, to RNA
interference (RNAi)-mediated knockdown of the wild-type endogenous USP1 (see the
Supplemental Experimental Procedures). Using this strategy (it included an RNAi-resistant
control messenger RNA [mRNA] encoding wild-type USP1), we examined the effect of
stabilizing the C-terminal fragment of the autocleaved USP1 on the in vivo levels of
monoubiquitylated PCNA and on the resistance of cells to UV. As expected (given the
Piatkov et al. Page 5
Mol Cell. Author manuscript; available in PMC 2014 January 13.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
results in Figure 3A), mutant USP1Q672M (it yields the long-lived Met-Usp1Ct fragment)
decreased the levels of monoubiquitylated PCNA, implying higher levels of DUB activity of
the autocleaved USP1 (Figure 3C). In agreement with these results, human U2OS cells
expressing the USP1Q672M mutant were reproducibly more sensitive to UV irradiation over
a range of UV doses than were identically treated cells expressing wild-type USP1 (Figure
3D).
Although there is still much to learn about specific mechanisms involved, our findings
(Figures 1, 2, 3, and S2) indicate a role of the Arg/N-end rule pathway in modulating,
through the degradation of the Gln-Usp1Ct fragment, the DUB activity of the autocleaved
Usp1, and thereby in modulating the levels of monoubiquitylated PCNA. Because
monoubiquitylated PCNA makes possible the lesion-bypassing, error-prone DNA synthesis,
the Arg/N-end rule pathway is also a regulator of DNA damage responses that involve error-
prone DNA replication. Other known functions of the Arg/N-end rule pathway in DNA
damage responses include the regulation, through selective degradation, of the S. cerevisiae
Mgt1 alkylguanine transferase, a DNA repair enzyme (Hwang et al., 2009). In sum, it is
likely that the Arg/N-end rule pathway mediates the regulated degradation not only of the
Gln-Usp1 fragment of Usp1 but also of other proteins that control the sensitivity of cells to
UV irradiation. This interpretation is consistent with the fact that genetic ablation of specific
branches of the Arg/N-end rule pathway in Ate1−/− and Ntaq1−/− EF cells studied in the
present work would make them even more UV sensitive that of the metabolic stabilization
of a specific UV-relevant Arg/N-end rule substrate such as Gln-Usp1.
Gln-Usp1Ct is the first physiological substrate of the Arg/N-end rule pathway that involves
the Ntaq1 NtQ-amidase and Gln-specific Nt-deamidation (Figures 1B and S1). A number of
questions remain to be addressed. For example, how does UV irradiation of cells increase
the autocleavage of Usp1? Is this autocleavage followed (or accompanied) by other
physiologically relevant modifications of this DUB, e.g., its phosphorylation or acetylation?
Such modifications might modulate the kinetics of targeting and degradation of the newly
formed Gln-Usp1Ct fragment, for example, by altering the steric accessibility of the newly
exposed N-terminal region of Gln-Usp1Ct to the Ntaq1 NtQ-amidase and downstream
components of the Arg/N-end rule pathway. Setting up and exploring an Arg/N-end rule-
based in vitro ubiquitylation/degradation system, with the Usp1-Uaf1 complex as its
autocleaved substrate, is likely to be a particularly informative approach to mechanistic
questions in this arena, and to some physiological questions as well.
EXPERIMENTAL PROCEDURES
Transfection and Immunoprecipitation
Mouse and human cell lines were transiently transfected with Fugene 6 (Roche) or
Lipofectamine 2000 (Invitrogen). Cells were lysed in Triton lysis buffer (1% Triton X-100,
50 mM NaCl, 2 mM EDTA, 50 mM Tris-HCl [pH 7.4]), and immunoprecipitations were
carried out with specific antibodies, as described in the Supplemental Experimental
Procedures.
In Vitro Transcription-Translation-Degradation Assay
Pulse-chase assays were carried out with the TNT T7 Coupled Transcription/Translation
System (Promega). Newly formed proteins were pulse-labeled with L-35S-methionine (MP
Biomedicals) for 10 min at 30°C. The labeling was quenched by the addition of
cycloheximide and unlabeled methionine. Reactions were terminated at indicated time
points, and flag-tagged proteins were immunoprecipitated with anti-flag antibody, followed
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by SDS-PAGE electrophoresis, autoradiography, and quantification, as described in the
Supplemental Experimental Procedures.
Construction of Ntaq1−/− Mouse Strains
Mouse embryonic stem cells containing an insert of a gene-trapping vector in the first intron
of the Ntaq1 gene (clone IST14542A4) were injected into C57BL/6J blastocysts and
implanted into pseudopregnant mouse females. The resulting chimeric male offspring were
mated with C57BL/6J females. Standard mating techniques (Joyner, 2000; Nagy et al.,
2003) were used to produce Ntaq1−/− mice. See the Supplemental Experimental Procedures.
UV Sensitivity Assay
Cells were trypsinized and plated at 300 cells per 35 mm tissue culture dish in triplicate.
After 12 hr, cells were treated with specified doses of 254 nm UV irradiation (Stratalinker
2400; Agilent Technologies), followed by recovery in complete medium. UV sensitivity was
scored 10 days later with the Syto-60 (Invitrogen) DNA staining kit. See the Supplemental
Experimental Procedures for details.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Gln-Usp1Ct, the Autogenerated C-Terminal Fragment of the Usp1 Deubiquitylase, Is a
Short-Lived Substrate of the Arg/N-End Rule Pathway
(A) Sequence alignments, among vertebrates, of the catalytic domains of Usp1 and its
autocleavage site, with amino acid residues numbered as in human USP1. The
corresponding domains of the structurally characterized human USP7, a USP-type
deubiquitylase (DUB) that lacks the autocleavage site (Hu et al., 2002), are also shown. Key
residues of the catalytic triad are in red, and are also marked by black circles. The Ub-like
domain (Ubl, in green) abuts the autocleavage site of Usp1. The Gln (Q) P1’ residue of the
autocleavage site is in red and a larger font size. This residue, #672 in human USP1 and
#670 in mouse Usp1, becomes N-terminal after the autocleavage.
(B) The enzymatic cascade that includes the Arg/N-end rule pathway, from the autocleavage
of Usp1 and modifications of the resulting Gln-Usp1Ct fragment by the Ntaq1 NtQ-amidase,
the Ate1 R-transferase, and UBR-type E3 Ub ligases (N-recognins) to the degradation of the
resulting Arg-Glu-Usp1Ct by the 26S proteasome.
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(C) The Ub reference technique (URT) assay (Piatkov et al., 2012; Varshavsky, 2005),
with fDHFR-UbR48, a flag-tagged derivative of the mouse dihydrofolate reductase, as the
reference protein.
(D) Gln-Usp1Ct, Glu-Usp1Ct, and Val-Usp1Ct (produced in reticulocyte extract from the
corresponding URT fusions) were labeled with 35S-Met/Cys for 10 min at 30°C, followed
by a chase, immunoprecipitation with anti-flag antibody, SDS-PAGE, and autoradiography.
(F) Quantification of data in E, using the fDHFR-UbR48 reference protein. Squares, Gln-
Usp1Ct; rhombs, Glu-Usp1Ct; triangles, Val-Usp1Ct.
See also Figure S1.
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Figure 2. In Vivo Degradation of the Endogenous Gln-Usp1Ct Fragment, Its Mutant, and Effects
of Mutations in the Arg/N-End Rule Pathway
(A) Cycloheximide (CHX) chase assays with endogenous Usp1 in wild-type, Ntaq1−/−, and
Ate1−/− mouse embryonic fibroblast (EF) cell lines. Full-length Usp1 and the Gln-Usp1Ct
fragment were detected by immunoblotting with an antibody (Huang et al., 2006), termed
anti-USP1Cterm, that recognizes a C-terminal region of mouse Usp1 or human USP1.
Immunoblotting with anti-tubulin antibody was used for loading controls.
(B) CHX chase for 0 and 3 hr with wild-type and Ntaq1−/− EF cell lines that had been
transiently transfected with a plasmid expressing mouse Usp1-myc. A monoclonal anti-myc
antibody was used to detect, by immunoblotting, full-length Usp1-myc and its autogenerated
Gln-Usp1Ct myc C-terminal fragment.
(C) CHX-chase for 0, 1, and 3 hr with a wild-type mouse EF cell line that had been
transiently transfected with plasmids expressing mouse Usp1-myc or Usp1G669A-myc.
Lanes 1–3, vector alone; lanes 4–6, Usp1-myc; lanes 7–9, Usp1G669A-myc.
(D) Same as in (C) but with Ate1−/− EF cells. Lanes 1–3, vector alone; lanes 4–6, Usp1-myc;
lanes 7–9, Usp1G669A-myc.
(E) Human U2OS cells were transiently transfected with plasmids expressing mouse Usp1-
myc (C-terminally tagged with the myc epitope), USP1G669A-myc (it cannot autocleave), or
USP1Q670A-myc (its autocleavage yields , whose N-terminal Ala is not
recognized by the Arg/N-end rule pathway). CHX chases were carried via immunoblotting
with anti-myc antibody. See also Figures S1 and S2.
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Figure 3. Metabolic Stabilization of the C-Terminal Fragment of Autocleaved Usp1 Decreases
Monoubiquitylation of PCNA and Increases UV Sensitivity of Cells
(A) Wild-type and Ate1−/− EF cells were either untreated or UV irradiated (254 nm; 50 J/
m2) and incubated for 3 hr, followed by SDS-PAGE of cell extracts and immunoblotting to
detect Usp1, Gln-Usp1Ct, PCNA, Chk1 (phosphorylated on Ser317), and tubulin.
Phosphorylated Chk1 was detected with the phospho-S317 Chk1 antibody (Abcam), to
verify that activation of the UV-induced DNA damage checkpoint was not significantly
affected by the absence of Ate1.
(B) Wild-type, Ntaq1−/−, and Ate1−/− mouse EF cell lines were either untreated or UV
irradiated at 2, 5, 10, and 50 J/m2, followed by incubation for 5 days and measurements of
the fraction of surviving cells using the SYTO-60 DNA staining technique (Invitrogen).
(C) Human U2OS cells were transfected at first with USP1-decreasing small interfering
RNA (siRNA) to deplete the endogenous USP1. Twenty-four hours later, cells were
transfected with plasmids that expressed siRNA-resistant mRNAs encoding either myc-
USP1 or myc-Usp1Q672M. The latter would yield, upon the autocleavage, the Met-Usp1Ct C-
terminal fragment whose N-terminal Met is not recognized by the Arg/N-end rule pathway,
in contrast to N-terminal Gln of wildtype Gln-Usp1Ct (Figure S1). Forty-eight hours after
the second transfection, cells were either left untreated or UV irradiated (254 nm, at 50 J/
m2), followed by a further incubation for 8 hr, SDS-PAGE of cell extracts, and
immunoblotting with both anti-myc and anti-USP1C-term antibodies, the latter detecting both
full-length USP1 and its C-terminal fragment.
(D) Same as in (C) but U2OS cells were either untreated or UV irradiated at 10 and 50 J/m2,
followed by incubation for 5 days and measurements of the fraction of surviving cells.
All assays in (B) and (D) were carried out in triplicate with standard deviations shown. See
also Figures S1 and S2.
Piatkov et al. Page 13
Mol Cell. Author manuscript; available in PMC 2014 January 13.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
